Literature DB >> 31326126

Myths and Misconceptions: Varicella-Zoster Virus Exposure, Infection Risks, Complications, and Treatments.

Alexander M Newman1, Ravi Jhaveri2.   

Abstract

Varicella zoster and herpes zoster are infections caused by the highly contagious varicella-zoster virus (VZV). Despite widespread availability of vaccines against VZV, as well as varicella vaccination rates >95%, VZV remains a public health concern because of several common myths and misconceptions. Because of the success of routine varicella vaccination programs, some people mistakenly believe that varicella and herpes zoster are now no longer a threat to public health. Another common misconception is that shingles is less infectious than varicella; however, clinical evidence indicates otherwise. Several knowledge gaps exist around VZV transmission and the availability and use of varicella zoster immune globulin (human) for postexposure prophylaxis against VZV. To help reduce the incidence of severe disease in high-risk individuals (eg, elderly people, pregnant women, unvaccinated persons, infants, and immunocompromised children and adults), this article addresses misbeliefs and broadens awareness of VZV exposure, infection risks, complications, and treatments.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  herpes zoster; postexposure prophylaxis; public health; varicella

Mesh:

Substances:

Year:  2019        PMID: 31326126     DOI: 10.1016/j.clinthera.2019.06.009

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  2 in total

1.  Chickenpox in an elderly man.

Authors:  Marcus G Tan; Jennifer Beecker
Journal:  Can Fam Physician       Date:  2020-08       Impact factor: 3.275

2.  Steroid Sensitive Nephrotic Syndrome: Revised Guidelines.

Authors:  Aditi Sinha; Arvind Bagga; Sushmita Banerjee; Kirtisudha Mishra; Amarjeet Mehta; Indira Agarwal; Susan Uthup; Abhijeet Saha; Om Prakash Mishra
Journal:  Indian Pediatr       Date:  2021-03-20       Impact factor: 1.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.